🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. placebo ketamine inj prep, KETAMINE RENAUDIN 10 mg/ml, solution injectable

    ISTA Pharma Limited

    Traumatism

    phase 3 small molecule active

    1 trial

  2. pneumococcal disease prevention

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Pneumococcal Vaccines

    phase 3 mab active

    1 trial

  3. poliovirus vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Poliomyelitis

    phase 3 mab completed

    1 trial

  4. preoperative short-course radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Neoplasms

    phase 3 other terminated

    1 trial

  5. probiotic strain Bb-12

    United Therapeutics Europe Ltd

    Infections, Respiratory

    phase 3 other completed

    1 trial

  6. probiotics, antibiotics or antidepressants

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome

    phase 3 small molecule active

    1 trial

  7. prucalopride

    Takeda

    Functional Constipation

    phase 3 small molecule completed

    1 trial

  8. radiation therapy

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 other completed

    1 trial

  9. relacorilant, CORT125134, Abraxane 5 mg/ml powder for dispersion for infusion.

    CORCEPT THERAPEUTICS INC

    Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

    phase 3 small molecule active

    1 trial

  10. rhIDU (recombinant human-Alpha-L-Iduronidase)

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis I

    phase 3 mab completed

    1 trial

  11. rhTPO in combination with Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule completed

    1 trial

  12. rifapentine

    Centers for Disease Control and Prevention

    Tuberculosis

    phase 3 small molecule completed

    2 trials

  13. riliprubart placebo, solution for injection in prefilled pen (PFP), riliprubart placebo, solution for injection in vial, riliprubart, riliprubart

    Sanofi-aventis Healthcare Pty Ltd

    Polyneuropathy, Inflammatory Demyelinating, Chronic

    phase 3 small molecule active

    1 trial

  14. riliprubart, -, riliprubart placebo solution for injection in prefilled pen, placebo matching IVIg, riliprubart, riliprubart placebo solution for injection in vial, -

    Sanofi-aventis Healthcare Pty Ltd

    Chronic Inflammatory Demyelinating Polyneuropathy

    phase 3 small molecule active

    1 trial

  15. sIPV-bOPV-bOPV vaccination schedule

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  16. sIPV-sIPV-bOPV vaccination schedule

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  17. sapropterin

    BioMarin Pharmaceutical Australia Pty Ltd

    Behavioral Manifestations of Lesch-Nyhan Disease

    phase 3 small molecule terminated

    1 trial

  18. sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonurias

    phase 3 small molecule completed

    1 trial

  19. shenfu injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    phase 3 small molecule active

    1 trial

  20. sildenafil

    Pfizer

    Hypertension, Pulmonary

    phase 3 small molecule completed

    1 trial

  21. sotatercept, PL1 - Powder for injection

    Lacuna Pharma Pty Ltd

    Therapeutic confirmatory (phase III)

    phase 3 small molecule active

    1 trial

  22. sotatercept, sotatercept

    Lacuna Pharma Pty Ltd

    Pulmonary Arterial Hypertension (PAH)

    phase 3 small molecule active

    1 trial

  23. sotrovimab

    Vir Biotechnology

    Covid19

    phase 3 mab terminated

    3 trials

  24. stavudine, efavirenz, lamivudine

    Bristol-Myers Squibb

    HIV Infections

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources